Our previous research found that NFIB was elevated in acid-adapted CRC cells11 and promoted tumor cell proliferation, invasion, and drug resistance in sorafenib-resistant hepatocellular carcinoma (HCC) cells12. The gene discussed is NFIB; the disease is hepatocellular carcinoma.